Abstract

microRNAs (miRNAs) are highly conserved, small non-coding RNAs that regulate gene expression at the posttranscriptional level. They have crucial roles in organismal development, homeostasis, and cellular responses to pathological stress. The lymphatic system is a large vascular network that actively regulates the immune response through antigen trafficking, cytokine secretion, and inducing peripheral tolerance. Here, we review the role of miRNAs in the lymphatic endothelium with a particular focus on their role in lymphatic endothelial cell (LEC) plasticity, inflammation, and regulatory function. We highlight the lineage plasticity of LECs during inflammation and the importance of understanding the regulatory role of miRNAs in these processes. We propose that targeting miRNA expression in lymphatic endothelium can be a novel strategy in treating human pathologies associated with lymphatic dysfunction.

Highlights

  • The lymphatic system is a transport network that regulates tissue fluid homeostasis, the absorption of macromolecules, and the trafficking of immune cells [1]

  • lymphatic vessel hyaluronan receptor-1 (LYVE-1) is a widely used lymphatic-specific marker, implicated in cellular trafficking and a homolog of the CD44 glycoprotein [12, 13]. Both vascular endothelial growth factor receptor-3 (VEGFR-3) and LYVE-1 are expressed during early endothelial cell development and become restricted to lymphatic endothelial cell (LEC) at later stages

  • MiR-1236 is lowly expressed in human LECs, it may be upregulated during inflammation-induced lymphangiogenesis to control the expression of VEGF-C/VEGFR-3 signaling

Read more

Summary

INTRODUCTION

The lymphatic system is a transport network that regulates tissue fluid homeostasis, the absorption of macromolecules, and the trafficking of immune cells [1]. In addition to transcriptional regulation, posttranscriptional mechanisms play a key role in LEC responses to inflammation. MiRNA-MEDIATED SILENCING microRNAs are a class of highly conserved, small non-coding RNA (~20–24 nt) that regulate gene expression at the posttranscriptional level of all biological pathways including cell development, differentiation, and function [2]. Binding sites are generally 8mers or canonical sites that enable high miRNA regulation of mRNA expression [6]. Due to this short target sequence, miRNAs can have multiple targets, and it is predicted that 30% of all protein-coding genes is under miRNA regulation in mammals [7]

EMBRYONIC DEVELOPMENT AND SPECIFICATION OF THE LYMPHATIC VASCULATURE
REGULATION OF THE miRNA BIOGENESIS MACHINERY IN LECs
LEC PLASTICITY
LECs IN INFLAMMATION AND LYMPHANGIOGENESIS
CONCLUDING REMARKS AND FUTURE DIRECTIONS
Inflammation Lineage commitment
Findings
HDLECs and corneal lymphatic vessels

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.